Entera BioENTX
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 22 institutions reported holding Entera Bio Ltd. (ENTX) in their 13F filings, unchanged from Q3 2025. 3 opened new positions and 4 sold out. The largest holders were Knoll Capital Management, LLC ($11.4M), Point72 Asset Management ($2.3M) and Marshall Wace, LLP ($1.2M). 3 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Entera Bio Ltd.
- CUSIP
- M40527109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $80K |
| Exits | 4 | $291K |
All 13F filers, Q3 2025 → Q4 2025: 174,587 shares bought and 176,135 shares sold, net −1,548 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Knoll Capital Management, LLC | 5.23% | No change | 5,881,879 | $11.4M |
| Point72 Asset Management | 0.00% | Add +1.3% | 1,193,653 | $2.3M |
| Marshall Wace, LLP | 0.00% | No change | 627,330 | $1.2M |
| Schonfeld Strategic Advisors LLC | 0.01% | Add +5.2% | 596,585 | $1.2M |
| Parkman Healthcare Partners LLC | 0.05% | Reduce -2.0% | 275,073 | $534K |
| Northern Trust Corp. | 0.00% | No change | 148,668 | $288K |
| Seven Fleet Capital Management LP | 0.18% | — | 135,318 | $263K |
| Renaissance Technologies | 0.00% | Add +22.2% | 108,001 | $210K |
| Jane Street Group, LLC | 0.00% | Add +142.6% | 74,064 | $144K |
| Susquehanna International Group, LLP | 0.00% | Reduce -3.4% | 64,910 | $126K |
| Signature Estate & Investment Advisors LLC | 0.00% | No change | 47,328 | $92K |
| HighTower Advisors, LLC | 0.00% | Add +137.8% | 43,140 | $84K |
| Citadel Advisors | 0.00% | Add +0.6% | 40,230 | $78K |
| Geode Capital Management, LLC | 0.00% | No change | 21,136 | $41K |
| Gem Investment Advisors, LLC | 0.04% | — | 19,135 | $37K |
| Superstring Capital Management LP | 0.02% | New | 17,142 | $33K |
| Bank of America Corp. | 0.00% | Reduce -28.6% | 15,000 | $29K |
| Goldman Sachs Group Inc. | 0.00% | New | 12,327 | $24K |
| Gsa Capital Partners LLP | 0.00% | New | 11,890 | $23K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 10,000 | $19K |
| Group One Trading LLC | 0.00% | No change | 51 | $99 |
| UBS Group AG | 0.00% | Reduce -99.8% | 17 | $33 |
"% of holder's portfolio" is ENTX's weight in each manager's 13F, not the share of Entera Bio Ltd. the manager owns.